NewsBenzingaアニクサ・バイオサイエンシズ、卵巣がん治療のためのFSHR標的CAR-T療法の第1相臨床試験における第5群への投与を完了 アニクサ・バイオサイエンシズ、卵巣がん治療のためのFSHR標的CAR-T療法の第1相臨床試験における第5群への投与を完了 Benzinga 2026.10.26 12:37 (GMT+0) Open on Benzinga Other news “AI Stock God” Leopold’s Fund Makes Sweeping Exit From Bitcoin Mining Stocks: IREN Position Slashed 94%, Several Miners Liquidated Wells Fargo: Get Paid to Wait: or Buy at a Discount Is a $1,100 Solana Price Realistic? Bitwise’s Model Has One Big Condition Royal Caribbean Cruises Stock Outlook: Is Wall Street Bullish or Bearish? Anthropic Keeps IPO Price Range Unchanged Daré Bioscience, Inc. (DARE) Q3 2026 Earnings Call Transcript
“AI Stock God” Leopold’s Fund Makes Sweeping Exit From Bitcoin Mining Stocks: IREN Position Slashed 94%, Several Miners Liquidated